231 related articles for article (PubMed ID: 36253738)
1. Prevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study.
Oraii A; Shafiee A; Jalali A; Alaeddini F; Saadat S; Masoudkabir F; Vasheghani-Farahani A; Heidari A; Sadeghian S; Boroumand M; Karimi A; H Franco O
BMC Endocr Disord; 2022 Oct; 22(1):248. PubMed ID: 36253738
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.
Moazzeni SS; Ghafelehbashi H; Hasheminia M; Parizadeh D; Ghanbarian A; Azizi F; Hadaegh F
BMC Public Health; 2020 Oct; 20(1):1510. PubMed ID: 33023566
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, awareness and risk factors of diabetes in Ahvaz (South West of Iran).
Yazdanpanah L; Shahbazian HB; Moravej Aleali A; Jahanshahi A; Ghanbari S; Latifi SM
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S114-8. PubMed ID: 27312373
[TBL] [Abstract][Full Text] [Related]
4. Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
Alizadeh Z; Baradaran HR; Kohansal K; Hadaegh F; Azizi F; Khalili D
Front Endocrinol (Lausanne); 2022; 13():1041808. PubMed ID: 36277718
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
[TBL] [Abstract][Full Text] [Related]
6. Pre-diabetes, Diabetes Mellitus and Related Cardio-metabolic Risk Factors in the Southern Coastal Region of Iran Middle-aged and Elderly Population; Bandare-Kong Cohort Study.
Ghaemmaghami Z; Eftekhar E; Shahbazi R; Nejatizadeh A; Shahmoradi M; Kheirandish M
Arch Iran Med; 2022 Jul; 25(7):409-416. PubMed ID: 36404506
[TBL] [Abstract][Full Text] [Related]
7. Burden and Socio-Behavioral Correlates of Uncontrolled Abnormal Glucose Metabolism in an Urban Population of India.
Mahapatra T; Chakraborty K; Mahapatra S; Mahapatra U; Pandey N; Thomson PL; Musk AW; Mitra RN
PLoS One; 2016; 11(10):e0163891. PubMed ID: 27755543
[TBL] [Abstract][Full Text] [Related]
8. Three-year change in glycemic state and the future risk of incident hypertension among Iranian adults: Tehran Lipid and Glucose Study.
Moazzeni SS; Dehghani S; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
J Hum Hypertens; 2023 Oct; 37(10):944-949. PubMed ID: 36473941
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, Awareness, Treatment, and Control of Hypertension among Adult Residents of Tehran: The Tehran Cohort Study.
Oraii A; Shafiee A; Jalali A; Alaeddini F; Saadat S; Sadeghian S; Poorhosseini H; Boroumand M; Karimi A; Franco OH
Glob Heart; 2022; 17(1):31. PubMed ID: 35586741
[TBL] [Abstract][Full Text] [Related]
10. Revising the fasting glucose threshold for detection of cardiovascular risk factors: analysing two representative population-based studies of more than 50,000 Iranians in 3 years: The National Survey of Risk Factors for Non-Communicable Diseases of Iran.
Esteghamati A; Zandieh A; Hafezi-Nejad N; Sheikhbahaei S; Abbasi M; Gouya MM; Nakhjavani M
Ann Hum Biol; 2015 Mar; 42(2):150-8. PubMed ID: 25019345
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, awareness, treatment and control of diabetes and impaired fasting glucose in the Southern Cone of Latin America.
Irazola V; Rubinstein A; Bazzano L; Calandrelli M; Chung-Shiuan C; Elorriaga N; Gutierrez L; Lanas F; Manfredi JA; Mores N; Olivera H; Poggio R; Ponzo J; Seron P; He J
PLoS One; 2017; 12(9):e0183953. PubMed ID: 28877254
[TBL] [Abstract][Full Text] [Related]
12. The 10-year trend of adult diabetes, prediabetes and associated risk factors in Tehran: Phases 1 and 4 of Tehran Lipid and Glucose Study.
Mahtab N; Farzad H; Mohsen B; Nakisa D
Diabetes Metab Syndr; 2017; 11(3):183-187. PubMed ID: 27666004
[TBL] [Abstract][Full Text] [Related]
13. Identification of Risk Factors Affecting Impaired Fasting Glucose and Diabetes in Adult Patients from Northeast China.
Yin Y; Han W; Wang Y; Zhang Y; Wu S; Zhang H; Jiang L; Wang R; Zhang P; Yu Y; Li B
Int J Environ Res Public Health; 2015 Oct; 12(10):12662-78. PubMed ID: 26473900
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of prediabetes, diabetes, diabetes awareness, treatment, and its socioeconomic inequality in west of Iran.
Moradpour F; Rezaei S; Piroozi B; Moradi G; Moradi Y; Piri N; Shokri A
Sci Rep; 2022 Oct; 12(1):17892. PubMed ID: 36284227
[TBL] [Abstract][Full Text] [Related]
15. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011.
Esteghamati A; Etemad K; Koohpayehzadeh J; Abbasi M; Meysamie A; Noshad S; Asgari F; Mousavizadeh M; Rafei A; Khajeh E; Neishaboury M; Sheikhbahaei S; Nakhjavani M
Diabetes Res Clin Pract; 2014 Feb; 103(2):319-27. PubMed ID: 24447808
[TBL] [Abstract][Full Text] [Related]
16. Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis.
Kohansal K; Masrouri S; Khalili D; Ramezankhani A; Azizi F; Blaha MJ; Hadaegh F
Cardiovasc Diabetol; 2022 Dec; 21(1):267. PubMed ID: 36463152
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study.
Mirzaei M; Rahmaninan M; Mirzaei M; Nadjarzadeh A; Dehghani Tafti AA
BMC Public Health; 2020 Feb; 20(1):166. PubMed ID: 32013917
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and determinants of diabetes and prediabetes in southwestern Iran: the Khuzestan comprehensive health study (KCHS).
Hariri S; Rahimi Z; Hashemi-Madani N; Mard SA; Hashemi F; Mohammadi Z; Danehchin L; Abolnezhadian F; Valipour A; Paridar Y; Mir-Nasseri MM; Khajavi A; Masoudi S; Alvand S; Cheraghian B; Shayesteh AA; Khamseh ME; Poustchi H
BMC Endocr Disord; 2021 Jun; 21(1):135. PubMed ID: 34187451
[TBL] [Abstract][Full Text] [Related]
19. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
[TBL] [Abstract][Full Text] [Related]
20. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
